Kiran Kalia

9.2k total citations · 4 hit papers
136 papers, 6.6k citations indexed

About

Kiran Kalia is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Kiran Kalia has authored 136 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 20 papers in Cancer Research and 20 papers in Biomedical Engineering. Recurrent topics in Kiran Kalia's work include MicroRNA in disease regulation (15 papers), Neuroinflammation and Neurodegeneration Mechanisms (14 papers) and Nanoparticle-Based Drug Delivery (14 papers). Kiran Kalia is often cited by papers focused on MicroRNA in disease regulation (15 papers), Neuroinflammation and Neurodegeneration Mechanisms (14 papers) and Nanoparticle-Based Drug Delivery (14 papers). Kiran Kalia collaborates with scholars based in India, United States and Sri Lanka. Kiran Kalia's co-authors include Rakesh Kumar Tekade, Dnyaneshwar Kalyane, Nidhi Raval, Rahul Maheshwari, Piyush Gondaliya, Vishakha Tambe, Pallab Bhattacharya, Dilip Kumar Sharma, Govinda Kapusetti and Vinod Tiwari and has published in prestigious journals such as PLoS ONE, Neurology and Scientific Reports.

In The Last Decade

Kiran Kalia

134 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Artificial intelligence in drug discovery and development

2020 850 citations Dnyaneshwar Kalyane, Kiran Kalia et al. Drug Discovery Today profile →
Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer

2019 676 citations Dnyaneshwar Kalyane, Nidhi Raval et al. profile →
Piezoelectric smart biomaterials for bone and cartilage tissue engineering

2018 337 citations Namdev More, Kiran Kalia et al. Inflammation and Regeneration profile →
Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics

2021 291 citations Ambika Chamoli, Santosh Kumar Behera et al. Oral Oncology profile →

Peers

Countries citing papers authored by Kiran Kalia

Since Specialization

Citations

This map shows the geographic impact of Kiran Kalia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiran Kalia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiran Kalia more than expected).

Fields of papers citing papers by Kiran Kalia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiran Kalia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiran Kalia. The network helps show where Kiran Kalia may publish in the future.

Co-authorship network of co-authors of Kiran Kalia

This figure shows the co-authorship network connecting the top 25 collaborators of Kiran Kalia. A scholar is included among the top collaborators of Kiran Kalia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiran Kalia. Kiran Kalia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Imidazopyrimidine-based pyruvate kinase M2 activator halts diabetic nephropathy progression via modulating epithelial-to-mesenchymal transition and fibrosis 2025 ·Chemico-Biological Interactions ·Meenakshi Jain, (unknown), Piyush Gondaliya, (unknown), (unknown), (unknown), Kiran Kalia, Amit Khairnar, Amit Shard	0
2	Exploration of Potent Cytotoxic Molecules from Fungi in Recent Past to Discover Plausible Anticancer Scaffolds 2022 ·Chemistry & Biodiversity ·(unknown), (unknown), (unknown), (unknown), Kiran Kalia, P.A. Paranagama, Abhijeet S. Kate	6
3	Bioprospecting of an Endolichenic Fungus Phanerochaete sordida Isolated from Mangrove-Associated Lichen Bactrospora myriadea 2022 ·Journal of Chemistry ·(unknown), (unknown), (unknown), (unknown), R.N. Attanayake, Abhijeet S. Kate, Gothamie Weerakoon, Santosh Kumar Behera, Kiran Kalia, P.A. Paranagama	1
4	Cytotoxic Bioxanthracene and Macrocyclic Polyester from Endolichenic Fungus Talaromyces pinophilus: In-Vitro and In-Silico Analysis 2022 ·Indian Journal of Microbiology ·(unknown), (unknown), (unknown), (unknown), (unknown), Santosh Kumar Behera, Kiran Kalia, P.A. Paranagama, Abhijeet S. Kate	1
5	Nanomaterials assisted chemo-photothermal therapy for combating cancer drug resistance 2022 ·Journal of Drug Delivery Science and Technology ·(unknown), (unknown), Vishakha Tambe, Dnyaneshwar Kalyane, Neelima Anup, Pran Kishore Deb, Kiran Kalia, Rakesh Kumar Tekade	26
6	Sirtuin 1 Mediated Modulation of Inflammasome Signaling Confers Neuroprotection in Rodent Model of Ischemic Stroke Following Endovascular Mesenchymal Stem Cell Therapy (S33.006) 2022 ·Neurology ·Deepaneeta Sarmah, Aishika Datta, (unknown), Kiran Kalia, Anne‐Marie Rodriguez, Dileep R. Yavagal, Pallab Bhattacharya	0
7	Post-stroke Impairment of the Blood–Brain Barrier and Perifocal Vasogenic Edema Is Alleviated by Endovascular Mesenchymal Stem Cell Administration: Modulation of the PKCδ/MMP9/AQP4-Mediated Pathway 2022 ·Molecular Neurobiology ·Aishika Datta, Deepaneeta Sarmah, Harpreet Kaur, (unknown), (unknown), Kiran Kalia, Anupom Borah, Dileep R. Yavagal, Pallab Bhattacharya	30
8	Identification of Novel Bioactive Compounds, Neurosporalol 1 and 2 from anEndolichenic Fungus, Neurospora ugadawe Inhabited in the Lichen Host,Graphis tsunodae Zahlbr. from Mangrove Ecosystem in Puttalam Lagoon, Sri Lanka 2021 ·Asian Journal of Chemistry ·(unknown), (unknown), R.N. Attanayake, (unknown), (unknown), Abhijeet S. Kate, Gothamie Weerakoon, (unknown), Kiran Kalia, P.A. Paranagama	4
9	Bioactive Properties and Metabolite Profiles of Endolichenic Fungi in Mangrove Ecosystem of Negombo Lagoon, Sri Lanka 2021 ·Natural Product Communications ·(unknown), (unknown), R.N. Attanayake, (unknown), Abhijeet S. Kate, Gothamie Weerakoon, Kiran Kalia, P.A. Paranagama	5
10	Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics breakdown → 2021 ·Oral Oncology ·Ambika Chamoli, (unknown), (unknown), (unknown), Santosh Kumar Behera, Nawneet K. Kurrey, Kiran Kalia, Amit Mandoli	291
11	Computational drug repurposing study elucidating simultaneous inhibition of entry and replication of novel corona virus by Grazoprevir 2021 ·Scientific Reports ·Santosh Kumar Behera, (unknown), (unknown), Amit Shard, Dinesh Kumar, Kiran Kalia, Alok Jain	37
12	Cerebro‐renal interaction and stroke 2020 ·European Journal of Neuroscience ·(unknown), (unknown), Deepaneeta Sarmah, Aishika Datta, (unknown), Ankan Kumar Sarkar, (unknown), (unknown), (unknown), Kiran Kalia, Anupom Borah, Kunjan R. Dave, Dileep R. Yavagal, Pallab Bhattacharya	15
13	Update on compatibility assessment of empagliflozin with the selected pharmaceutical excipients employed in solid dosage forms by thermal, spectroscopic and chromatographic techniques 2020 ·Drug Development and Industrial Pharmacy ·(unknown), Suryanarayana Polaka, (unknown), Kiran Kalia, Abhijeet S. Kate	14
14	Fast dissolving electrospun polymeric films of anti-diabetic drug repaglinide: formulation and evaluation 2019 ·Drug Development and Industrial Pharmacy ·Shreya Thakkar, Namdev More, Dilip Kumar Sharma, Govinda Kapusetti, Kiran Kalia, Manju Misra	34
15	Plant-Derived Bioactive Peptides: A Treatment to Cure Diabetes 2019 ·International Journal of Peptide Research and Therapeutics ·(unknown), (unknown), Kiran Kalia, Abhijeet S. Kate	94
16	Method and its Composition for encapsulation, stabilization, and delivery of siRNA in Anionic polymeric nanoplex: An In vitro- In vivo Assessment 2019 ·Scientific Reports ·Nidhi Raval, (unknown), Piyush Gondaliya, Kiran Kalia, Rakesh Kumar Tekade	42
17	Nanogold-core multifunctional dendrimer for pulsatile chemo-, photothermal- and photodynamic- therapy of rheumatoid arthritis 2019 ·Journal of Colloid and Interface Science ·(unknown), Rahul Maheshwari, Nidhi Raval, Piyush Gondaliya, Kiran Kalia, Rakesh Kumar Tekade	79
18	Piezoelectric smart biomaterials for bone and cartilage tissue engineering breakdown → 2018 ·Inflammation and Regeneration ·(unknown), Namdev More, Kiran Kalia, Govinda Kapusetti	337
19	The use of nanoscaffolds and dendrimers in tissue engineering 2017 ·Drug Discovery Today ·Bapi Gorain, Muktika Tekade, Prashant Kesharwani, Arun K. Iyer, Kiran Kalia, Rakesh Kumar Tekade	75
20	Efficacy of urinary n-acetyl β- D-Glucosaminidase in detecting renal tubular damage: An early consequence in Type 2 diabetes mellitus leading to Diabetic nephropathy 2014 ·Endocrinology & Metabolic Syndrome ·Kiran Kalia, Dhara Patel	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact